Deputy Director of the Coronary Artery Disease Center, specializing in intravascular imaging and QFR
Affiliated HospitalFuwai Hospital, Chinese Academy of Medical Sciences
→
Research areas: Coronary artery disease and complex coronary interventional treatment, intravascular imaging and physiology of the coronary arteries.
Cutting-edge technology: Co-first author of the FAVOR III China study published in *The Lancet* (impact factor 207), confirming that QFR-guided coronary intervention can significantly improve prognosis. Invited by *The Lancet* as the sole author from China to participate in writing a major global report on "Ischemic Heart Disease". Drafted the National Health Commission's *Guideline for Coronary Balloon Angioplasty and Stent Implantation*. Principal investigator of a National Science and Technology Major Project (RMB 100,000).
Areas of expertise: Coronary artery disease, interventional treatment of complex coronary artery lesions, intravascular imaging and functional assessment of coronary arteries.
Academic Highlights and Core Values: Director of the Coronary Artery Disease Ward 1, Deputy Director of the Coronary Artery Disease Center, Head of the Interventional Catheterization Laboratory, and Principal Investigator at the National Clinical Research Center for Cardiovascular Diseases. Recipient of the 2017 CIT Young Physician Research Award and the 2024 National Advanced Worker in the Health System. The core laboratory platform has a permanent research team of two people.